Summary Company Announcement Date: February 25, 2025 FDA Publish Date: February 26, 2025 Product Type: Dietary SupplementsDrugs Reason for Announcement: Recall Reason Description Undeclared Tadalafil Company […]

Summary Company Announcement Date: October 02, 2023 FDA Publish Date: October 02, 2023 Product Type: Drugs Reason for Announcement: Recall Reason Description Potential Presence of Glass […]

FDA is engaged in efforts to encourage innovations in manufacturing processes and technology and to foster a quality management system. Emerging Technology Program FDA meets early […]

Drug Safety Priorities FY 2024(PDF – 1.8 MB) Drug Safety is a Key Priority at the Center for Drug Evaluation and Research CDER Drug Safety Priorities […]

Summary Company Announcement Date: February 24, 2025 FDA Publish Date: February 25, 2025 Product Type: Drugs Reason for Announcement: Recall Reason Description Due to visible black […]

[ 9-15-2015 ] The U.S. Food and Drug Administration (FDA) is making changes to the requirements for monitoring, prescribing, dispensing, and receiving the schizophrenia medicine clozapine, […]

Summary Company Announcement Date: February 25, 2025 FDA Publish Date: February 25, 2025 Product Type: Drugs Reason for Announcement: Recall Reason Description Microbial contamination of the […]

FDA is evaluating the root cause of benzene contamination in certain drugs and alerting drug manufacturers to the risk of benzene contamination from drug components and […]

Image Español If you have a complaint about a product regulated by the U.S. Food and Drug Administration (FDA), the agency wants to hear about it. […]